SG11201703516XA - Uses of il-12 as an hematopoietic immunotherapy (hit) - Google Patents
Uses of il-12 as an hematopoietic immunotherapy (hit)Info
- Publication number
- SG11201703516XA SG11201703516XA SG11201703516XA SG11201703516XA SG11201703516XA SG 11201703516X A SG11201703516X A SG 11201703516XA SG 11201703516X A SG11201703516X A SG 11201703516XA SG 11201703516X A SG11201703516X A SG 11201703516XA SG 11201703516X A SG11201703516X A SG 11201703516XA
- Authority
- SG
- Singapore
- Prior art keywords
- immunotherapy
- hematopoietic
- hit
- hematopoietic immunotherapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462073220P | 2014-10-31 | 2014-10-31 | |
| PCT/US2015/058363 WO2016070075A1 (en) | 2014-10-31 | 2015-10-30 | Uses of il-12 as an hematopoietic immunotherapy (hit) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201703516XA true SG11201703516XA (en) | 2017-05-30 |
Family
ID=55851469
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703516XA SG11201703516XA (en) | 2014-10-31 | 2015-10-30 | Uses of il-12 as an hematopoietic immunotherapy (hit) |
| SG10202103474YA SG10202103474YA (en) | 2014-10-31 | 2015-10-30 | Uses of il-12 as an hematopoietic immunotherapy (hit) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202103474YA SG10202103474YA (en) | 2014-10-31 | 2015-10-30 | Uses of il-12 as an hematopoietic immunotherapy (hit) |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160120949A1 (en) |
| EP (1) | EP3212215A4 (en) |
| JP (1) | JP2017533279A (en) |
| KR (1) | KR20170088861A (en) |
| CN (1) | CN107708724A (en) |
| AU (2) | AU2015338998A1 (en) |
| CA (1) | CA2966218A1 (en) |
| HK (1) | HK1250653A1 (en) |
| IL (1) | IL251956A0 (en) |
| SG (2) | SG11201703516XA (en) |
| WO (1) | WO2016070075A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10293058B2 (en) | 2015-04-22 | 2019-05-21 | Curevac Ag | RNA containing composition for treatment of tumor diseases |
| KR101779370B1 (en) | 2016-06-29 | 2017-09-19 | 한국수력원자력 주식회사 | Apoptosis regulatory gene detected irradiated-thymic lymphoma and detecting method of thereof |
| KR20190039145A (en) * | 2016-07-18 | 2019-04-10 | 뉴메디슨즈, 인코포레이티드 | Use of IL-12 as an alternative immunotherapy |
| WO2019126384A1 (en) * | 2017-12-19 | 2019-06-27 | Neumedicines Inc. | Effective il-12 dosing regimens |
| CN113557242A (en) * | 2019-02-01 | 2021-10-26 | 得克萨斯大学体系董事会 | Modified IL-12T cell therapy for treating cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7939058B2 (en) * | 2003-07-03 | 2011-05-10 | University Of Southern California | Uses of IL-12 in hematopoiesis |
| US20090047241A1 (en) * | 2007-06-20 | 2009-02-19 | University Of Southern California | Il-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation |
| US9878012B2 (en) * | 2010-05-18 | 2018-01-30 | Neumedicines, Inc. | IL-12 formulations for enhancing hematopoiesis |
| EP2804620A4 (en) * | 2012-01-18 | 2016-04-13 | Neumedicines Inc | Il-12 for radiation protection and radiation-induced toxicity mitigation |
| WO2014160318A1 (en) * | 2013-03-13 | 2014-10-02 | Neumedicines, Inc. | Endogenous vaccine for cancer and infectious diseases |
-
2015
- 2015-10-30 CA CA2966218A patent/CA2966218A1/en not_active Abandoned
- 2015-10-30 US US14/928,499 patent/US20160120949A1/en not_active Abandoned
- 2015-10-30 WO PCT/US2015/058363 patent/WO2016070075A1/en active Application Filing
- 2015-10-30 SG SG11201703516XA patent/SG11201703516XA/en unknown
- 2015-10-30 JP JP2017542806A patent/JP2017533279A/en active Pending
- 2015-10-30 EP EP15854096.3A patent/EP3212215A4/en not_active Withdrawn
- 2015-10-30 CN CN201580071486.0A patent/CN107708724A/en active Pending
- 2015-10-30 KR KR1020177014518A patent/KR20170088861A/en not_active IP Right Cessation
- 2015-10-30 SG SG10202103474YA patent/SG10202103474YA/en unknown
- 2015-10-30 AU AU2015338998A patent/AU2015338998A1/en not_active Abandoned
-
2017
- 2017-04-26 IL IL251956A patent/IL251956A0/en unknown
-
2018
- 2018-08-08 HK HK18110202.3A patent/HK1250653A1/en unknown
-
2021
- 2021-08-05 AU AU2021212068A patent/AU2021212068A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HK1250653A1 (en) | 2019-01-11 |
| AU2015338998A1 (en) | 2017-05-18 |
| WO2016070075A1 (en) | 2016-05-06 |
| SG10202103474YA (en) | 2021-05-28 |
| JP2017533279A (en) | 2017-11-09 |
| AU2021212068A1 (en) | 2021-08-26 |
| CN107708724A (en) | 2018-02-16 |
| US20160120949A1 (en) | 2016-05-05 |
| EP3212215A1 (en) | 2017-09-06 |
| IL251956A0 (en) | 2017-06-29 |
| CA2966218A1 (en) | 2016-05-06 |
| EP3212215A4 (en) | 2018-07-11 |
| KR20170088861A (en) | 2017-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1231509A1 (en) | Culture medium composition | |
| IL246681A0 (en) | Compounds and compositions for immunotherapy | |
| IL253341B (en) | Methods and compositions for combination immunotherapy | |
| SG11201609635XA (en) | Novel high clarity low haze compositions | |
| SG10201912608UA (en) | Turbo chiller | |
| EP3125895A4 (en) | Substituted spirocydic inhibitors of autotaxin | |
| GB201413564D0 (en) | Time of flight determination | |
| EP3218443A4 (en) | Refrigerant compositions and methods of use | |
| PT3107573T (en) | Cancer-targeted il-12 immunotherapy | |
| HK1250653A1 (en) | Uses of il-12 as an hematopoietic immunotherapy (hit) | |
| EP3129753A4 (en) | Compositions and methods for delivery of carbon dioxide | |
| EP3190886A4 (en) | Compositions and methods of use thereof | |
| IL248194A0 (en) | Acrylic resin compositions, materials comprising same and methods of manufactoring same | |
| EP3127287A4 (en) | Signaling and operation of an mmtp de-capsulation buffer | |
| SG11201701402QA (en) | Anti-tumor compositions and methods | |
| EP3376862A4 (en) | Cryopreservative compositions and methods of use thereof | |
| SG10202007893TA (en) | Methods of immunotherapy | |
| PL3223846T3 (en) | Adjuvant compositions and related methods | |
| HK1243404A1 (en) | Tryptamide compositions and methods of use | |
| PL3113774T3 (en) | Compositions of grapiprant and methods for using the same | |
| EP3228322B8 (en) | Adjuvant composition | |
| IL250269A0 (en) | Repeated fed-batch culture methods | |
| GB2532702B (en) | The determination of the characteristics of magnets | |
| GB201404700D0 (en) | Novel Composition | |
| GB201412359D0 (en) | Composition of objects |